scholarly article | Q13442814 |
P50 | author | A Clinton White | Q44838503 |
Pablo C Okhuysen | Q54425139 | ||
Prema Robinson | Q58806841 | ||
P2093 | author name string | D E Lewis | |
P C Okhuysen | |||
A C White | |||
C L Chappell | |||
I Shahab | |||
S Lahoti | |||
P2860 | cites work | A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells | Q24678065 |
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonists | Q30304239 | ||
Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine. | Q30465882 | ||
Growth factors in inflammatory bowel disease | Q33535516 | ||
Gastrointestinal mucosal regeneration: role of growth factors | Q33541262 | ||
Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model | Q33654292 | ||
Regulatory T cells and inflammatory bowel disease | Q33740189 | ||
Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function | Q33815039 | ||
The infectivity of Cryptosporidium parvum in healthy volunteers | Q34319487 | ||
Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii | Q35546330 | ||
Granuloma cytokines in murine cysticercosis | Q35551593 | ||
Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii | Q36367127 | ||
Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum | Q39569830 | ||
Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation | Q41370537 | ||
Healing the epithelium: solving the problem from two sides | Q41371678 | ||
Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta | Q41517331 | ||
Intensity of infection in AIDS-associated cryptosporidiosis | Q43957052 | ||
Virulence of three distinct Cryptosporidium parvum isolates for healthy adults | Q44137804 | ||
TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii | Q44636873 | ||
Effector and regulatory lymphoid cells and cytokines in mucosal sites. | Q47606873 | ||
Interferon‐γ Expression in Jejunal Biopsies in Experimental Human Cryptosporidiosis Correlates with Prior Sensitization and Control of Oocyst Excretion | Q58646616 | ||
Intestinal function and injury in acquired immunodeficiency syndrome—related cryptosporidiosis | Q58646695 | ||
TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice | Q73748161 | ||
The Pathogenesis of Mucosal Inflammation in Murine Models of Inflammatory Bowel Disease and Crohn Disease | Q74583424 | ||
Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum | Q74687192 | ||
Site-specific changes in transforming growth factor-alpha and -beta1 expression in colonic mucosa of adolescents with inflammatory bowel disease | Q78107350 | ||
Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G | Q78167287 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Cryptosporidium parvum | Q134734 |
P304 | page(s) | 5405-5407 | |
P577 | publication date | 2000-09-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans | |
P478 | volume | 68 |
Q37864135 | Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans |
Q34006110 | Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms. |
Q92856287 | Heat stress, Eimeria spp. and C. perfringens infections alone or in combination modify gut Th1/Th2 cytokine balance and avian necrotic enteritis pathogenesis |
Q37704368 | Human immune responses in cryptosporidiosis |
Q90935826 | Immune response and protective efficacy of Eimeria tenella recombinant refractile body protein, EtSO7, in chickens |
Q26765938 | Infection Strategies of Intestinal Parasite Pathogens and Host Cell Responses |
Q39792290 | Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction |
Q36984727 | Intestinal immune response to human Cryptosporidium sp. infection. |
Q40685644 | Modulation of the immune response by infection with Cryptosporidium spp. in children with allergic diseases. |
Q53861788 | Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice. |
Q43893601 | Oral bovine serum concentrate improves cryptosporidial enteritis in calves |
Q47134278 | Potential Sabotage of Host Cell Physiology by Apicomplexan Parasites for Their Survival Benefits |
Q35089632 | The cell biology of cryptosporidium infection |